PE20080286A1 - Composicion que incluye superoxido dismutasa y cactus nopal para disminuir y prevenir la resaca - Google Patents

Composicion que incluye superoxido dismutasa y cactus nopal para disminuir y prevenir la resaca

Info

Publication number
PE20080286A1
PE20080286A1 PE2007000956A PE2007000956A PE20080286A1 PE 20080286 A1 PE20080286 A1 PE 20080286A1 PE 2007000956 A PE2007000956 A PE 2007000956A PE 2007000956 A PE2007000956 A PE 2007000956A PE 20080286 A1 PE20080286 A1 PE 20080286A1
Authority
PE
Peru
Prior art keywords
nopal
cactus
reduce
composition including
superoxide dismutase
Prior art date
Application number
PE2007000956A
Other languages
English (en)
Inventor
Victor Hugo Diaz
Original Assignee
Victor Hugo Diaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Victor Hugo Diaz filed Critical Victor Hugo Diaz
Publication of PE20080286A1 publication Critical patent/PE20080286A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE: A) SUPEROXIDO DISMUTASA EN UNA CANTIDAD DE 50 A 300MG; B) CACTUS NOPAL EN UNA CANTIDAD DE 250 A 800MG; C) SESAMIN EN UNA CANTIDAD DE 250 A 500MG; D) ACIDO ALFA LIPOICO EN UNA CANTIDAD DE 50 A 300MG; Y E) OTROS COMPUESTOS TALES COMO TIAMINA, NIACINA, FOLATO, VITAMINA B12, ACIDO PANTOTENICO, EXTRACTO DE GINGO BILOBA, CAFEINA, ENTRE OTROS. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE LA RESACA INDUCIDA POR ALCOHOL
PE2007000956A 2006-07-24 2007-07-24 Composicion que incluye superoxido dismutasa y cactus nopal para disminuir y prevenir la resaca PE20080286A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/493,480 US7879374B2 (en) 2005-07-22 2006-07-24 Composition including superoxide dismutase and prickly-pear cactus for minimizing and preventing hangovers

Publications (1)

Publication Number Publication Date
PE20080286A1 true PE20080286A1 (es) 2008-05-21

Family

ID=38971742

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000956A PE20080286A1 (es) 2006-07-24 2007-07-24 Composicion que incluye superoxido dismutasa y cactus nopal para disminuir y prevenir la resaca

Country Status (5)

Country Link
US (1) US7879374B2 (es)
AR (1) AR062042A1 (es)
CL (1) CL2007001940A1 (es)
PE (1) PE20080286A1 (es)
WO (1) WO2008014256A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100209557A1 (en) * 2009-02-14 2010-08-19 O'connor Daniel C Recovery blends for liquid beverages
US20100316735A1 (en) * 2009-04-10 2010-12-16 Wade Belliston Compositions and methods for reducing hangover symptoms
US8377907B1 (en) 2011-02-21 2013-02-19 William A. Halamicek, III Compositions for treating alcohol hangover
US10251924B2 (en) * 2013-09-25 2019-04-09 Northern Innovations Holding Corp Compositions containing myristica fragrans
IT201700119556A1 (it) * 2017-10-23 2019-04-23 Glauco Isella Integratore alimentare energizzante e suo uso.
CA3012021A1 (en) * 2018-07-20 2020-01-20 Detoxicated Inc. Composition and method for the alleviation of effects of alcohol consumption
IL311104A (en) 2019-06-11 2024-04-01 Advance Pharmaceutical Inc Superoxide soluble fiber components
CN114271490A (zh) * 2021-12-02 2022-04-05 深圳中科欣扬生物科技有限公司 一种含sod和麦角硫因的抗疲劳抗氧化和解酒功能的保健配方

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1379149A (en) * 1920-09-03 1921-05-24 John C Wichmann Process of making rubber-like material and resulting product
US2980587A (en) * 1955-03-21 1961-04-18 Philips Corp Dry stable vitamin a and/or d-preparation and methods of producing same
US4496548A (en) * 1983-02-04 1985-01-29 Moldowan Mervin J Composition and method for reducing hangover
GB8325627D0 (en) * 1983-09-24 1983-10-26 Scras Therapeutic compositions
US5538878A (en) * 1988-08-08 1996-07-23 Calgene, Inc. Superoxide dismutase expression in plants
US6451341B1 (en) * 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US6228347B1 (en) 1997-12-01 2001-05-08 Thione International, Inc. Antioxidant gel for gingival conditions
EP0960572A1 (en) * 1998-05-12 1999-12-01 N.V. Nutricia Nutritional composition for the treatment of pressure ulcers
US6229347B1 (en) * 1999-01-11 2001-05-08 United Microelectronics, Corp. Circuit for evaluating an asysmetric antenna effect
KR100318223B1 (ko) * 1999-07-05 2001-12-22 김찬식 페피노 추출물을 함유하는 혈중알콜농도 저하용 조성물 및 그 제조방법
US6485758B2 (en) * 2000-02-18 2002-11-26 Vasolabs, Inc. Hangover treatment
US6447820B1 (en) * 2001-01-22 2002-09-10 Sarfaraz K Niazi Pharmaceutical composition for the prevention and treatment of scar tissue
US6365198B1 (en) * 2001-01-28 2002-04-02 Gulf Pharmaceutical Industries Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids
JP2003070444A (ja) * 2001-06-19 2003-03-11 Kawakami Trading Inc 添加剤、食品、飲料、調味料及び化粧品
KR100523562B1 (ko) 2001-10-29 2005-10-25 한국과학기술연구원 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물
US20040082667A1 (en) * 2002-10-16 2004-04-29 Mccadden Kenneth Hangover treatment
US7371413B2 (en) * 2003-05-05 2008-05-13 Rutgers, The State University Antioxidant and anti-inflammatory activity of compounds and preparations from African nutmeg seeds
US7956031B2 (en) * 2005-05-31 2011-06-07 Naidu Lp Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy

Also Published As

Publication number Publication date
WO2008014256A2 (en) 2008-01-31
US20080020071A1 (en) 2008-01-24
CL2007001940A1 (es) 2008-02-29
AR062042A1 (es) 2008-08-10
WO2008014256A3 (en) 2008-12-11
US7879374B2 (en) 2011-02-01

Similar Documents

Publication Publication Date Title
PE20080286A1 (es) Composicion que incluye superoxido dismutasa y cactus nopal para disminuir y prevenir la resaca
CL2007001166A1 (es) Compuestos derivados de pirimidina condensada, inhibidores de pi3-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicion farmaceutica
PE20211069A1 (es) Composicion que comprende 5'-metilselenoadenosina, selenoadenosil-l-homocisteina y gama glutamil-metilselenocisteina
CR20150174A (es) Composición esterilizada que comprende al menos un ácido hialuronico y ascorbil fosfato de magnesio
UY32072A (es) Tienopirimidinas para composiciones farmacéuticas
CL2013001982A1 (es) Metodo para reducir los niveles de glucosa y tratar trastornos del metabolismo de la misma; composicion farmaceutica que comprende metformina y otro agente antidiabetico o antiobesidad.
CL2012002317A1 (es) Compuestos derivados de tienopirimidinas, inhibitores de quinasas mnk1/mnk2; composicion farmaceutica; y su uso para elt ratamiento o profilaxis de enfermedades metabolicas, tales como diabetes, daño renal, cancer, enfermedades inflamatorias, entre otras.
UY35472A (es) Compuestos y sus usos en la modulacion de la hemoglobina
AR053803A1 (es) Uso de acido pinolenico
CO6781465A2 (es) Composición farmacéutica, métodos de tratamiento y usos de la misma
AR051704A1 (es) Composicion para el consumo humano que brinda mejoras en la concentracion de la agudeza mental
CL2012002318A1 (es) Compuestos derivados de tieno [2,3-d]pirimidina, inhibidores de quinasa mnk1 y mnk2; composición farmaceutica; que los comprende; y su uso en el tratamiento de enfermedades metabolicas, hematopoyeticas, neurodegenerativas, renales, inflamatorias y cancer.
CL2011000488A1 (es) Compuestos derivados de pirazolo-pirimidinas sustituidas; composicion y combinacion farmaceutica que los comprenden; y su uso como inhibidores de pde9 para el tratamiento, alivio y/o prevencion de deterioros cognitivos relacionados con la percepcion, alzheimer,trastornos del sueño, trastorno bipolar, diabetes mellitus.
GT200600200A (es) Composicion farmaceutica que contienen gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato
BR112013020753A2 (pt) método para extrair corpos oleosos, corpos oleosos secos, composição, uso de corpos oleosos, gênero alimentício ou ingrediente, produto para cuidado pessoal, e, uso de um corpo oleoso seco
CO6382089A2 (es) Compuestos,composiciones y metodos para el tratamiento de enfermadades causadas por un b-amiloide y sinucleinopatias
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
AR094074A1 (es) Composiciones que contienen iones de metales estables
CL2013002700A1 (es) Cápsula suave ingerible que contiene inositol y excipientes, o inositol, excipientes y al menos un principio activo adicional, tal como ácido fólico, polifenoles de cocoa, genisteína, l-arginina, vitamina e, selenio, n-acetilcisteína y melatonina; útil para el tratamiento del ovario poliquístico, resistencia a la insulina y otros
GT201500035A (es) Composición farmacéutica oral en forma de microesferas y proceso de elaboración
AR090940A1 (es) Procedimiento para la fabricacion de una forma farmaceutica que comprende nifedipino y candesartan cilexetilo
CL2007001748A1 (es) Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras.
AR074454A1 (es) Compuestos 4-(-heterocicloalquil) benceno-1,3-diol como inhibidores de la tirosinasa, y su uso en medicina humana y tambien en cosmetica
ECSP088722A (es) Formulaciones medicamentosas que contienen fluoroquinolonas
CL2008003372A1 (es) Compuestos derivados de metil-bencimidazol, procedimiento de preparacion, composicion farmaceutica que los contiene y uso en el tratamiento y/o profilaxis de enfermedades afectadas por moduladores de fxr, en particular, dislipidemia, enfermedades de absorcion de colesterol y aterosclerosis, entre otras.

Legal Events

Date Code Title Description
FC Refusal